Clinical trial

Provigil in Conjunction With SSRIs for the Treatment of Mild or Moderate…

NCT00208715 · Emory University, Other · Completed

Key facts

NCT number NCT00208715
Title Provigil in Conjunction With SSRIs for the Treatment of Mild or Moderate Depression With Attendant Symptoms of Sleepiness and Fatigue.
Official title A DOUBLE-BLIND PILOT STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PROVIGIL® (MODAFINIL) AT FIXED/FLEXIBLE DOSES, IN CONJUNCTION WITH IDENTIFIED SSRIs FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PATIENTS WITH MILD TO MODERATE DEPRESSION WITH ATTENDANT SYMPTOMS OF SLEEPINESS AND FATIGUE
Lead sponsor Emory University, Other
Collaborators Cephalon Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Major Depression, Mental Health
Intervention type Drug
Interventions Provigil
Enrollment 100
Start date Feb 1, 2003
Completion Oct 1, 2004
First posted Sep 21, 2005
Last update posted Nov 11, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies